Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734975 · ClinicalTrials.gov registry record · Phase 2
Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
A Phase 2 study of Vocal Cord Disease and Vocal Cord Polyp, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT06734975: Recruiting Phase 2 study of Vocal Cord Disease and Vocal Cord Polyp, sponsored by Rutgers, The State University of New Jersey.
NCT06734975 is a Phase 2 study of Vocal Cord Disease and Vocal Cord Polyp that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06734975, a Phase 2 study of Vocal Cord Disease and Vocal Cord Polyp, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.
Conditions Studied
Interventions
- DRUG Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension)
- DRUG Superior laryngeal nerve block - Placebo (saline)
Study Locations (1)
New Jersey
- Rutgers New Jersey Medical School - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06734975
The ClinicalTrials.gov registry entry for NCT06734975 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vocal Cord Disease appearing as the primary indexed condition, and to 2 interventions - of which Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension) is the first listed.
NCT06734975 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06734975 about?
NCT06734975 is a clinical study titled "Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery". Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.
What is the current status of trial NCT06734975?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2025-07-11. Estimated completion is 2026-12.
What conditions does trial NCT06734975 study?
This clinical trial studies the following conditions: Vocal Cord Disease, Vocal Cord Polyp, Vocal Cord Cyst.
What interventions are being tested in trial NCT06734975?
The interventions under investigation include: Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension) (DRUG), Superior laryngeal nerve block - Placebo (saline) (DRUG).
Who is sponsoring clinical trial NCT06734975?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06734975 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.